In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FATAHINIA MAHNAZ; Halvaeizadeh Marzieh; ZAREI MAHMOUDABADI ALI; ABOUALIGALEHDARI ELHAM; KIASAT NEDA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Current Medical Mycology Year:2020 | Volume:6 | Issue:2 Page(s): 1-6

Download Full-Text

View:

142

Download:

Cites:

Information Journal Paper

Title

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

Author(s)

Keywords

Ahvaz

Antifungal susceptibility test

Candida glabrata

Abstract

Background and Purpose: Candida glabrata is the second cause of candidiasis. The mortality rate of C. glabrata infections is about 40%; accordingly, it may be life threatening, especially in immunocompromised hosts. Regarding this, the current study was conducted to evaluate the regional patterns of the antifungal susceptibility of clinical C. glabrata isolated from the patients referring to the health centers located in Ahvaz, Iran. Materials and Methods: In this study, a total of 30 clinical strains of C. glabrata isolates were recovered from different body sites (i. e., vagina, mouth, and urine). Phenotypic characteristics and molecular methods were used to identify the isolates. The minimum inhibitory concentration (MIC) was determined according to the European Committee on Antimicrobial Susceptibility Testing. Results: Our findings demonstrated that 20%, 80%, and 6. 7% of the isolates were resistant to amphotericin B, terbinafine, and posaconazole, respectively, while all the isolates were found to be fluconazole susceptible dose dependent and susceptible to voriconazole and caspofungin. Conclusion: Our study suggested that voriconazole had high potency against C. glabrata isolates. Consequently, this antifungal agent can be an alternative drug in the treatment of resistant patients. These results can be helpful for the successful treatment of patients in different regions.

Cites

No record.

References

Cite

APA: Copy

FATAHINIA, MAHNAZ, Halvaeizadeh, Marzieh, ZAREI MAHMOUDABADI, ALI, ABOUALIGALEHDARI, ELHAM, & KIASAT, NEDA. (2020). In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST. CURRENT MEDICAL MYCOLOGY, 6(2), 1-6. SID. https://sid.ir/paper/774227/en

Vancouver: Copy

FATAHINIA MAHNAZ, Halvaeizadeh Marzieh, ZAREI MAHMOUDABADI ALI, ABOUALIGALEHDARI ELHAM, KIASAT NEDA. In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST. CURRENT MEDICAL MYCOLOGY[Internet]. 2020;6(2):1-6. Available from: https://sid.ir/paper/774227/en

IEEE: Copy

MAHNAZ FATAHINIA, Marzieh Halvaeizadeh, ALI ZAREI MAHMOUDABADI, ELHAM ABOUALIGALEHDARI, and NEDA KIASAT, “In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST,” CURRENT MEDICAL MYCOLOGY, vol. 6, no. 2, pp. 1–6, 2020, [Online]. Available: https://sid.ir/paper/774227/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops